05:32 PM EST, 11/27/2024 (MT Newswires) -- Jeffrey V. Poulton, EVP, Chief Financial Officer, on Nov. 25 and Nov. 26, sold 1,682 shares in Alnylam Pharmaceuticals ( ALNY ) for $422,144. Following the Form 4 filing with the SEC, Poulton has control over a total of 30,701 shares of the company, with 30,644 shares held directly and 57 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000106/xslF345X05/edgardoc.xml